HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.10
+7.14%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.16
- Revenue estimate
- $24.1K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.10
- EPS estimate
- -$0.19
- Revenue actual
- $27.0K
- Revenue estimate
- $27.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -668.1%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.19 | -$0.10 | Beat 47.37% | $27.0K |
| May 12, 2026 | -$0.18 | -$0.15 | Beat 16.67% | $31.6K |
| Mar 26, 2026 | -$0.47 | -$0.47 | In line | $36.6K |
| Nov 14, 2025 | -$0.11 | -$3.12 | Miss -2736.36% | $34.6K |
| Aug 14, 2025 | — | -$2.25 | — | $1.2M |
| May 20, 2025 | — | $19 | — | $1.1M |
| Nov 14, 2024 | -$5.80 | -$3.11 | Beat 46.38% | $2.3M |
| Aug 14, 2024 | -$6.96 | -$3.49 | Beat 49.86% | $2.0M |
| May 15, 2024 | -$0.16 | -$5.23 | Miss -3168.75% | $1.9M |
| Feb 23, 2024 | -$0.18 | -$0.11 | Beat 38.89% | $2.0M |
| May 15, 2023 | -$4.21 | -$91 | Miss -2054.39% | $2.3M |
| Nov 14, 2022 | -$18 | -$552 | Miss -3011.72% | $2.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026